3 ms·
Vaccines may lessen long Covid for some, but more study is needed
- mdp2021 4y agoMore clearly: "vaccines as a potential treatment for long COVID". > Vaccination after infection with SARS-CoV-2... is associated with a decrease in the likelihood of long COVID symptoms, finds a large study of U.K. adults published today by the [British Medical Journal, ...] at least in the first few months after vaccination // They stress that causality cannot be inferred from this observational evidence [...] Evidence... suggests that long COVID is reduced in those who are infected after vaccination, but the effectiveness of vaccination on pre-existing long COVID is less clear > Researchers ... drew on ONS data for [~28000] adults... who received at least one COVID-19 vaccine dose after testing positive for SARS-CoV-2 infection... then tracked the presence of long COVID symptoms over a seven month follow-up period (February to September 2021). Long COVID symptoms of any severity were reported by... 24% at least once during follow-up. A first vaccine dose was associated with an initial 13% decrease in the odds of long COVID, but it is unclear from the data whether this improvement was sustained over the following 12 weeks, until a second vaccine dose was given. Receiving a second vaccine dose was associated with a further 9% decrease in the odds of long COVID, and this improvement was sustained at least over an average follow-up of nine weeks Original research article: Manoj Sivan et al, Are vaccines a potential treatment for long covid?, BMJ (2022) https://dx.doi.org/10.1136/bmj.o988 https://dx.doi.org/10.1136/bmj.o988 The abstract shows numbers can swing considerably (sometimes also indicating possible worsenings: «Another small study by Tsuchida et al measured antibody titres and symptoms post-vaccination in 42 adults with long covid: 61% reported no change in symptoms, 21% reported worse symptoms, and 16% reported an improvement during the two weeks after vaccination»), and success ratios comparatively high but relatively low («At 120 days, 16.6% of those vaccinated reported complete resolution of symptoms, compared with 7.5% of those who were unvaccinated»).